Cargando…

Corticosteroids in acute respiratory distress syndrome: outcomes obscured by mortality

Detalles Bibliográficos
Autor principal:	Oh, Dong Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820638/ https://www.ncbi.nlm.nih.gov/pubmed/33472286 http://dx.doi.org/10.3904/kjim.2020.619

Ejemplares similares

COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Association of Economic Status and Mortality in Patients with Acute Respiratory Distress Syndrome
por: Oh, Tak Kyu, et al.
Publicado: (2020)

Acute Respiratory Distress Syndrome in the Elderly
por: Jagathkar, Ganshyam
Publicado: (2021)

The effectiveness of Corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis
por: Zhang, Zhongheng, et al.
Publicado: (2015)

Can acute respiratory distress syndrome be treated?
por: Christman, John W, et al.
Publicado: (2021)

COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome
por: Vidal-Cortés, Pablo, et al.
Publicado: (2020)

Obscurity on Obesity
por: Winkler, Jack
Publicado: (2014)

An Obscure Case
Publicado: (1877)

Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome
por: Chopra, Amit, et al.
Publicado: (2020)

Do we know enough to recommend corticosteroids in acute respiratory distress syndrome?
por: Blot, Mathieu, et al.
Publicado: (2017)

Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid
por: Ahmad, Farrukh
Publicado: (2022)

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome
por: Yin, Jun, et al.
Publicado: (2018)

The attributable mortality of acute respiratory distress syndrome
por: Auriemma, Catherine L., et al.
Publicado: (2020)

Pharmacotherapy for Acute Respiratory Distress Syndrome: Limited Success to Date
por: Jeon, Kyeongman
Publicado: (2017)

Equipoise and Acumen in Pediatric Acute Respiratory Distress Syndrome Research
por: Oishi, Peter, et al.
Publicado: (2020)

Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome
por: Matthay, Michael A., et al.
Publicado: (2020)

Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome. An Index that ROX
por: Hill, Nicholas S., et al.
Publicado: (2019)

Obscure Tumour—Sudden Death
Publicado: (1854)

Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis
por: Ruan, Sheng-Yuan, et al.
Publicado: (2014)

Serum total bilirubin, an indicator for the impact of hemoglobin catabolism on outcome of patients with the acute respiratory distress syndrome
por: Graw, Jan A.
Publicado: (2022)

Liponucleotides: Promises and Unknowns as Novel Therapeutics for Acute Respiratory Distress Syndrome
por: Hung, Chi F., et al.
Publicado: (2021)

Hypoxemia on life support for guiding acute respiratory distress syndrome therapy?
por: Gusman, Elen, et al.
Publicado: (2020)

Acute Respiratory Distress Syndrome (ARDS): Pathophysiological Insights and Lung Imaging
por: Perchiazzi, Gaetano, et al.
Publicado: (2019)

Pediatric Acute Respiratory Distress Syndrome in India: Time for Collaborative Study?
por: Solomon, Rekha
Publicado: (2022)

Targeting Protease Activity to Interrupt Acute Respiratory Distress Syndrome Pathogenesis
por: Shaver, Ciara M.
Publicado: (2022)

Physiology Is Vital to Precision Medicine in Acute Respiratory Distress Syndrome and Sepsis
por: Goligher, Ewan C., et al.
Publicado: (2022)

Improving Acute Respiratory Distress Syndrome Diagnosis: Is Lung Ultrasound the Answer?
por: Ware, Lorraine B.
Publicado: (2023)

Noninvasive ventilation on mortality of acute respiratory distress syndrome
por: Ye, Ling, et al.
Publicado: (2016)

The Transcriptional Signature in Alveolar Macrophages Dictates Acute Respiratory Distress Outcomes
por: Tejwani, Vickram, et al.
Publicado: (2019)

Acute kidney injury in acute respiratory distress syndrome: why ventilator settings matter
por: Vashisht, Rishik, et al.
Publicado: (2020)

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
por: Goursaud, Suzanne, et al.
Publicado: (2020)

Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
por: Villar, Jesús, et al.
Publicado: (2020)

Protecting the Injured Right Ventricle in COVID-19 Acute Respiratory Distress Syndrome: Can Clinicians Personalize Interventions and Reduce Mortality?
por: Zochios, Vasileios, et al.
Publicado: (2021)

The Staying Power of Pressure- and Volume-limited Ventilation in Acute Respiratory Distress Syndrome
por: Beitler, Jeremy R., et al.
Publicado: (2021)

Lung and chest wall mechanics in COVID-19 acute respiratory distress syndrome
por: Pearce, Alex K., et al.
Publicado: (2021)

Dampening the Fire: A Negative Feedback Loop in Acute Respiratory Distress Syndrome
por: Liu, Jing, et al.
Publicado: (2021)

Dead space in acute respiratory distress syndrome: more than a feeling!
por: Blanch, Lluis, et al.
Publicado: (2016)

Machine Learning Classifier Models: The Future for Acute Respiratory Distress Syndrome Phenotyping?
por: McNicholas, Bairbre, et al.
Publicado: (2020)

Maximal Lung Recruitment in Acute Respiratory Distress Syndrome: A Nail in the Coffin
por: Mancebo, Jordi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bdvuhc9rj5p3rrte92ujtlu549